Lately approved protein therapeutics have been developed to treat a wide variety of clinical disorders, such as infections, cancers, autoimmunity/inflammation, and genetic disorders. Creative Biolabs can generate a variety of complement system-related proteins, which could be qualified tools for the early discovery process in life science research and groundbreaking development of specific clinical applications.
